
Veracyte Appoints Brent Shafer and Tom Miller, Ph.D. to Board of Directors
Key Highlights
- Veracyte appoints Brent Shafer and Tom Miller, Ph.D., to its board.
- Brent Shafer brings over 40 years of experience in healthcare and medical devices.
- Tom Miller, Ph.D., is a leader in AI-driven drug discovery and biotech.
- Both will contribute to Veracyte’s strategic growth in diagnostics and AI.
Source: Business Wire
Notable Quotes
“ We are thrilled to welcome Brent and Tom to our board. ”
Marc Stapley, CEO at Veracyte
“ I am thrilled to join the Veracyte board to support the management team in advancing their vision. ”
Brent Shafer, former CEO at Cerner
“ It’s an honor to be a part of a company with such a compelling platform. ”
Tom Miller, Ph.D., CEO at Iambic Therapeutics